Vimarsana
Biggest News Aggregation in the World

Study Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Endpoints Today - Breaking & Trending Today

Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating) - Vimarsana News

Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

Published: March 18, 2023

/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...

Source: prnewswire.com
Related Topics:
United StatesEastern Virginia Medical SchoolNew OrleansSuzanne HaberDavid PariserVirginia Clinical Research IncInternational Hyperhidrosis SocietyDrug AdministrationOffice TreatmentCandesant Biomedical IncConsumer Survey On Cosmetic Dermatologic ProceduresAmerican Society For Dermatologic SurgerySweat SolutionsCanadian Hyperhidrosis Advisory CommitteeAmerican Academy Of DermatologyEastern Virginia Medical School Department Of DermatologyStudy EndpointsAmerican AcademyHyperhidrosis Disease Severity ScaleEastern Virginia Medical School DepartmentVirginia Clinical ResearchInternational HyperhidrosisAmerican SocietyDermatologic SurgeryExcessive Axillary Sweating
Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society - Vimarsana News

Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society

Published: December 2, 2021

/PRNewswire/ -- Neurelis, Inc. will present a collection of 16 posters describing safety, tolerability and effectiveness results observed in trials evaluating...

Source: prnewswire.com
Related Topics:
United StatesEnrique CarrazanaAdrianl RabinowiczMark LeonardSchool SettingAmerican Epilepsy SocietyTiming To AdministrationDrug AdministrationSchool Nurse Survey To Understand Current PracticesNeurelis IncSecond Dose AdministrationClinical DevelopmentAmerican Epilepsy Society DecemberNeurelis Chief Medical OfficerDrug ExclusivitySenior Vice PresidentMedical AffairsNasal SpraySecond Dose Administration WithinPopulation PharmacokineticOpen Label PharmacokineticSafety TrialDiazepam Nasal SprayOld With SeizureEpilepsy Scale From
Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society - Vimarsana News

Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society

Published: December 2, 2021

/PRNewswire/ -- Neurelis, Inc. will present a collection of 16 posters describing safety, tolerability and effectiveness results observed in trials evaluating...

Source: prnewswire.com
Related Topics:
United StatesEnrique CarrazanaAdrianl RabinowiczMark LeonardSchool SettingAmerican Epilepsy SocietyTiming To AdministrationDrug AdministrationSchool Nurse Survey To Understand Current PracticesNeurelis IncSecond Dose AdministrationClinical DevelopmentAmerican Epilepsy Society DecemberNeurelis Chief Medical OfficerDrug ExclusivitySenior Vice PresidentMedical AffairsNasal SpraySecond Dose Administration WithinPopulation PharmacokineticOpen Label PharmacokineticSafety TrialDiazepam Nasal SprayOld With SeizureEpilepsy Scale From